New Eye Scan May Catch Diabetic Eye Damage Earlier

What Was Studied and Why It Matters

Researchers reviewed 23 studies published between 2010 and 2025 to evaluate a specialized eye-scanning technology called Laser Speckle Flowgraphy, or LSFG. This non-invasive imaging tool measures blood flow in the retina — the light-sensitive tissue at the back of your eye — by bouncing laser light off blood cells and analyzing the patterns it creates. The review focused on how well LSFG works for detecting and monitoring diabetic retinopathy (DR), the leading cause of vision loss in people with diabetes.

Diabetic retinopathy affects nearly one in three people with diabetes. Catching it early — before it causes noticeable vision changes — is critical to preventing permanent damage. That's exactly why researchers are excited about LSFG.

What the Research Found

Across the 23 studies involving 783 eyes with diabetic retinopathy, LSFG revealed several important findings:

• Early warning signs in healthy-looking eyes: LSFG detected tiny blood flow problems even in eyes that appeared normal during standard eye exams, suggesting it can spot damage before it becomes visible with conventional tools.
• Blood sugar is directly connected to eye blood flow: The scan's measurements correlated closely with HbA1c levels — your 3-month blood sugar average. Higher blood sugar meant measurably worse blood flow in the retina.
• Predicting treatment success: Eyes with lower baseline blood flow readings responded less well to treatment for diabetic macular edema (swelling in the central part of the retina), helping doctors identify who may need more aggressive care.
• Tracking the effects of treatments: LSFG clearly showed how different treatments — including anti-VEGF injections and laser therapy — affect retinal blood flow, helping doctors compare their effectiveness.

What This Means for Real Patients

If you have diabetes, this research matters to you in a very practical way. Right now, routine eye exams can miss early-stage retinopathy. By the time damage is visible, some of it may already be irreversible. LSFG could change that timeline significantly.

This technology is non-invasive — no needles, no dye injections — and produces results quickly. As it moves toward wider clinical use, it may become part of your regular diabetes eye care, helping your eye doctor personalize your treatment plan based on your actual retinal blood flow rather than waiting for visible symptoms.

Managing your blood sugar remains the most powerful tool you have. Pairing good glucose control — supported by reliable supplies from MDS Diabetes — with emerging diagnostic tools like LSFG represents exactly the kind of proactive, personalized approach that modern diabetes care is moving toward.

Bottom Line

A specialized laser eye scan called LSFG can detect blood flow problems in diabetic eyes earlier than standard exams, predict how well certain treatments will work, and track disease progression more precisely. While not yet widely available, it represents a meaningful step toward catching diabetic eye disease sooner — when treatment is most effective. In the meantime, keeping your HbA1c in your target range remains your best defense against retinopathy.